Healthcare Specialty Enzymes Market Size, Share & Trends Analysis Report By Source (Carbohydrases, Proteases), By Product, By Technique, By Application, By Usage, By End Use, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global healthcare specialty enzymes market size was exhibited at USD 3.72 billion in 2022 and is projected to hit around USD 6.86 billion by 2032, growing at a CAGR of 6.3% during the forecast period 2023 to 2032.

Key Pointers:

• North America dominated the market for healthcare specialty enzymes and accounted for the largest revenue share of 45.2% in 2022.
• The microbial enzymes segment accounted for the largest revenue share of 49.1% in 2022 
• The clinical chemistry segment dominated the market for healthcare specialty enzymes and accounted for over 36.0% of revenue share in 2022
• Healthcare specialty enzymes find tremendous applications in the research as well as clinical space, thereby accounted for the largest revenue share of 69.7% in 2022. 
• Infectious diseases dominated the market for healthcare specialty enzymes with the largest revenue share of 33.9% in 2022. 
• Laboratories held the maximum revenue share of 50.8% in 20222

Healthcare Specialty Enzymes Market Report Scope

Enzymes are complex proteins capable of inducing chemical changes in other substances without being changed themselves. The specificity of enzymes to certain tissues or organs aids in identifying the site of damage, which helps in disease diagnosis. Changing levels of Lactate Dehydrogenase (LDH) in the blood is a preferred approach to detect the onset of cardiovascular diseases; this enzyme is specifically found in the heart and skeletal muscle in two distinguished forms.

Specialty enzymes are employed in various diagnostic applications such as DNA manipulation and sequencing. Decline in cost of DNA manipulation and sequencing is projected to drive the demand and increase usage of enzymes in research & biotechnology and pharmaceuticals applications. Increase in geriatric population in developed countries is also anticipated to propel the demand for healthcare specialty enzymes. Research & biotechnology application of enzymes is estimated to increase at a rapid pace, as advances in diagnostic tests due to decline in DNA sequencing costs are likely to lead to increase in testing in agricultural, food, and medical applications. Moreover, large pharmaceutical companies continue to boost research & development spending on biologics to expand their new drug pipelines.

Investments by various multinational enzyme manufacturers operating in the global healthcare specialty enzymes market, such as Novozymes, Codexis, and Biocatalysts, has been increasing for the last few years. The healthcare specialty enzymes market is driven by continued investment in biotechnology and genetics, as pharmaceutical companies rely on biotechnology to overcome difficulties in introducing successful new small molecule drugs to the market.

The enzyme industry is concentrated, with top players dominating the market. This is because enzyme products require specialized knowledge of manufacturing processes such as fermentation. Technical and niche nature of the business, reliance on R&D, and shortage of qualified professionals act as entry barriers for new players in the global specialty enzyme market.

North America dominated the market for healthcare specialty enzymes and accounted for the largest revenue share of 45.2% in 2022. Introduction of new policies, such as Affordable Care Act, has increased the demand for high-quality healthcare facilities. Demand for preventive healthcare is another factor driving the healthcare specialty enzymes market, which in turn is fueling the healthcare specialty enzymes market in North America.

Developing economies in Asia Pacific and Latin America provide significant opportunities in the healthcare specialty enzymes market owing to government initiatives, such as awareness programs and increase in geriatric population that is more prone to metabolic diseases and certain metabolic disorders that would lead to a large potential patient base, is likely to boost the healthcare specialty enzymes market in these regions

Some of the prominent players in the Healthcare Specialty Enzymes Market include:

• Advanced Enzymes Technologies Ltd
• Amano Enzymes, Inc.
• Amicogen
• BBI Solutions
• biotechrabbit GmbH
• Brain AG
• CPC Biotech
• Creative Enzymes
• EKF Diagnostics
• F. Hoffmann-La Roche Ltd
• Merck KGaA
• Sekisui Chemical Co., Ltd.
• Thermo Fisher Scientific, Inc.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Healthcare Specialty Enzymes market.

By Product 

• Carbohydrases
• Polymerases and Nucleases
• Proteases
• Lipases
• Phosphatases/Phytases
• Other Products

By Source 

• Micro-organisms
• Animals
• Plants

By Technique 

• Clinical Chemistry
• Immunodiagnostics/Immunoassays
• Molecular Diagnostics
• Hematology
• Microbiology

By Usage 

• Research & Biotechnology
• Diagnosis

By Application 

• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Diseases

By End-use 

• Hospitals
• Laboratory
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)